-
Biotech set for good start to 2021
Biotechs have fared better in 2020 than companies in many other industries. Despite the disruption caused by the pandemic, biopharma companies have been able to raise record sums of capital,...
-
Possible treatment for COVID-19 related respiratory failure
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Jonathan Javitt, CEO of NeuroRx. Dr Javitt discusses how NeuroRx...
-
Transforming the treatment of cancer with oncolytic viruses
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Stephen Russell, CEO of Vyriad. Dr. Russell reveals invaluable...
-
Early planning key to successful access and product launch
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Alison Kneen, Senior Vice President, Global Market Access and Head of the Centre of...
-
Impact of COVID-19 on MedTech Regulatory Bodies & Health Agencies
In addition to highlighting current and anticipated challenges and considering the long-term impact of the COVID-19 pandemic, this E-Book outlines how regulators and agencies in the US, Europe, and...
-
COVID-19, multi-stem clinical trials and a new way of fundraising
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Gil Van Bokkelen, founder, chairman and CEO of Athersys Inc. They discuss the company’s...
-
Maximising R+D efforts through better epidemiology understanding
In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, talks to Mike Hughes, Senior Director of Epidemiology at DRG. With...
-
Addressing strategic challenges for biotech companies
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, talks to Dr Srikanth Rajagopal (or Doc, as he is fondly referred to). Doc, a partner at DRG...
-
With in-person avenues reduced, U.S. physicians turn to online tools
U.S. physicians' use of virtual consults has soared since spring Use of virtual consultations Among U.S. physicians Source: DRG, Taking the Pulse® U.S. 2017, 2018, 2019, and 2020, and Re-Taking...
-
Bringing together minds to combat COVID-19
In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Sir Mene Pangalos, Executive Vice President at AstraZeneca. Sir...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
